Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds

Home > Past Briefings > Briefing Detail Page

Briefing Detail Page

Change Text Size:   Smaller Text Size   Larger Text Size   Default Text Size    

Prospects for Health Care: Where Will New Congressional Leadership Take Us?

Friday, December 08, 2006

Come January, we can expect to see some new approaches to health legislation. Sen. Harry Reid, incoming Senate majority leader, says one of his top three priorities will be more funding for stem cell research. House Speaker-to-be Nancy Pelosi wants a vote early on to roll back the prohibition against the federal government negotiating prescription drug prices for Medicare beneficiaries. And these are just two of the health issues likely to be debated in the new Congress. The White House too will have a definite voice in the debates to come.

What will the health related priorities of the congressional leadership and the White House be? Will the Medicare program change the way it pays providers and deals with pharmaceutical companies? Are there changes in store for SCHIP with reauthorization next year? What are the prospects for FDA reform? How will the Administration and the Congress react to the Medicaid commission’s recent recommendations? Will the federal government follow the lead of some states and address the problem of the uninsured?

To discuss these and related questions, the Alliance for Health Reform and the Kaiser Family Foundation sponsored a December 8 briefing. Panelists included: Julie Goon, White House domestic policy staff; Wendell Primus, Office of presumptive Speaker of the House, Nancy Pelosi; Kate Leone, Office of incoming Senate Majority Leader, Harry Reid and Elizabeth Hall, Office of Senate Majority Leader, William H. Frist.


Julie Goon, White House domestic policy staff, Speaker
Wendell Primus, Office of presumptive Speaker of the House, Nancy Pelosi, Speaker
Kate Leone, Office of incoming Senate Majority Leader, Harry Reid, Speaker
Elizabeth Hall, Office of Senate Majority Leader William H. Frist, Speaker

Transcript, Event Summary and/or Webcast and Podcast

Transcript: Transcript: Prospects for Health Care: Where Will New Congressional Leadership Take Us? (Adobe Acrobat PDF), 12/8/2006
Full Webcast/Podcast: Webcast: Prospects for Health Care:Where Will New Congressional Leadership Take Us?

The transcript, full webcast and podcast for this briefing are provided by Kaiser Family Foundation.

Source Materials

Statement of Senator John D. Rockefeller IV (Word Document), Senator Rockefeller’s Office, 9/19/2006
Speaker Biographies: Prospects for Health Care (Word Document), , 12/8/2006

Offsite Materials (briefing documents saved on other websites)

A Case Study of the Utah Primary Care network Waiver: insights into its development, design, & , Teh Boston Glob, 11/10/2006
Democratic leaders eye FDA reforms, The Executive, 11/16/2006
Pelosi – One the Issues – Healthcare, Pelosi Official Web sight, 11/1/2006
Sen. Kennedy Outlines Goals for Senate HELP Committee, Including Universal Coverage for All U.S, Kaiser Family Foundation (, 11/17/2006
Press Release: Grassley Introduces Bill to Help States Fund Health Care for Low-Income Children, United States Senator Chuck Grassley of Iowa Official Websight, 9/28/2006
SCHIP Financing Update: In 2007, 17 States Will Face Federal Funding Shortfalls of $890 Million (Adobe Acrobat PDF),Center on Budget and Policy Priorities, 11/21/2006
AP Interview: Leader of Democrats in next Congress says ethics reform, minimum wage and stem ce, International Herald Tribune, 11/28/2006
Harry Reid- Issues: Health Care, Harry Reid Official Websight, 5/6/2006
Sen. Baucus to Tackle Health Care Costs,, 11/16/2006
Drug Industry Is on Defensive As Power Shifts, New York Times Online , 11/24/2006
Success of Drug Plan Challenges Democrats, Washington Post, 11/26/2006
US Election: Implications of Democratic control for healthcare, Goldman Sachs, 9/1/2006
Healthcare Industries Still Amongst Most Popular Targets for More Regulation but Support for Re, The Harris Poll People- Healthcare News, 11/14/2006
Health’s Ailment; A new Congress may patch up a few problems, but don’t expect a cure, U.S. News & World Report, 11/20/2006


Wendell Primus, office of presumptive Speaker of the House, Nancy Pelosi -- speaker at the December 8th briefing cosponsored by the Kaiser Family Foundation.

Kate Leone, office of incoming Senate Majority Leader Harry Reid --speaker at the December 8th briefing cosponsored by the Kaiser Family Foundation.

Elizabeth Hall, office of Majority Leader William H. Frist -- speaker at the December 8th briefing cosponsored by the Kaiser Family Foundation.

Julie Goon, White House domestic policy staff -- speaker at the December 8th briefing cosponsored by the Kaiser Family Foundation.

Diane Rowland -- moderator at the December 8th briefing cosponsored by the Kaiser Family Foundation.


Toolkit: Emergency Preparedness in the U.S.: The Ebola Threat

Is the U.S. prepared for a potential virulent pandemic? This new Alliance toolkit examines public health infrastructure, funding and policy levers that deal with these kinds of health crises in America.

Read More 

Mike Leavitt Video: Consolidation and Control-The Evolving Health Care System

Mike Leavitt, chairman of Leavitt Partners and former HHS secretary, addresses the aggressive repositioning of players in the evolving health care system in a new Alliance for Health Reform video.

Read More 

Telemedicine Toolkit: The Promise and Challenges

The integration of technology and health care is on the rise. Although evidence shows that telemedicine has improved access to health care and resulted in lower costs in rural and underserved areas, challenges to expansion include reimbursement policies and acceptable security measures. A new Alliance for Health Reform Toolkit, “Telemedicine: The Promise and Challenges,” addresses the effectiveness of telemedicine as a tool for communication, as well as the expected outcomes and challenges ahead.

Read More 

Toolkit on Long-Term Services and Supports (LTSS)

The aging of the baby boomers and the increase in the number of old-old persons (those 85 and older) are predictors for the increasing need for long-term services and supports (LTSS). Among persons age 65 and over, an estimated 70 percent will use LTSS. A new Alliance for Health Reform toolkit, “Long-Term Services and Supports: Changes and Challenges in Financing and Delivery,” provides a background on LTSS and discusses policy issues surrounding the topic.

Read More 

Experts Discuss Workplace Wellness Programs

In a new interview video, Karen Pollitz, senior fellow, private insurance and health reforms, The Kaiser Family Foundation and Dan Newton, vice president, product/solutions development and behavior economics, Anthem Care Management discuss the impact of workplace wellness programs. They address questions about regulations and program design and analyze the scope of wellness programs.

Read More 

Alliance Search for New CEO

WASHINGTON, DC (Aug. 3) – Edward F. Howard, founding executive vice president and CEO of the Alliance for Health Reform in Washington, DC, will retire in March 2016. A nationwide search is underway for his successor.

Over the years, the Alliance has presented hundreds of seminars on Capitol Hill and elsewhere, has organized briefings for reporters around the country and has prepared dozens of issue briefs and “toolkits,” as well as a series of highly-regarded sourcebooks for reporters on health policy topics.

Dr. Robert Graham, Chairman of the Board, noted that the search for a new CEO is being coordinated by Association Strategies of Alexandria, Va. Those interested in learning more about this opportunity should email or call 703/ 683-0580. You can also view the position profile on their website. The deadline for applications is Monday, October 12. 

Read More
Position Profile

Read More 

Toolkit on Biosimilars

The Alliance for Health Reform has released a new toolkit, “Biosimilars: Unpacking Complex Issues.”

The Affordable Care Act created an expedited licensure pathway for biosimilars, and, in March 2015, the U.S. approved the first biosimilar, leaving policy makers, regulators, providers and stakeholders to grapple with regulatory and financial questions.

Biosimilars are similar – but not identical – to biologic drugs, and cost less. Unlike traditional pharmaceuticals, biologic drugs are derived from living organisms and tissues, making them more complex and expensive to produce.

Read More 

Copyright 1997-2015 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      Sitemap